Xiaopei Yan

407 total citations
10 papers, 321 citations indexed

About

Xiaopei Yan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiaopei Yan has authored 10 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Xiaopei Yan's work include Antifungal resistance and susceptibility (2 papers), Pleural and Pulmonary Diseases (2 papers) and Fungal Infections and Studies (2 papers). Xiaopei Yan is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), Pleural and Pulmonary Diseases (2 papers) and Fungal Infections and Studies (2 papers). Xiaopei Yan collaborates with scholars based in China. Xiaopei Yan's co-authors include Weiping Xie, Yanli Wang, Hui Kong, Wenrui Liu, Xiaoning Zeng, Hong Wang, Jingjing Wang, Fang Zhou, Hong Wang and Xiang Li and has published in prestigious journals such as Experimental Cell Research, Oncology Reports and Acta Physiologica.

In The Last Decade

Xiaopei Yan

10 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaopei Yan China	7	211	99	94	60	40	10	321
Yuehan Wei China	8	145 0.7×	104 1.1×	46 0.5×	66 1.1×	24 0.6×	14	293
Keng Ye China	8	181 0.9×	63 0.6×	95 1.0×	34 0.6×	34 0.8×	14	325
Zongwei Lin China	10	204 1.0×	36 0.4×	74 0.8×	90 1.5×	30 0.8×	19	388
Dina Polosukhina United States	11	212 1.0×	76 0.8×	95 1.0×	41 0.7×	90 2.3×	12	347
Angelica Intini Italy	4	118 0.6×	85 0.9×	60 0.6×	58 1.0×	79 2.0×	5	304
Gizem A. Gökalp United States	3	98 0.5×	107 1.1×	71 0.8×	42 0.7×	21 0.5×	3	275
Shaochun Bai United States	11	150 0.7×	49 0.5×	36 0.4×	44 0.7×	49 1.2×	24	362
Dayan Cao China	11	120 0.6×	34 0.3×	118 1.3×	29 0.5×	47 1.2×	18	319
Yingjian Jiang China	9	163 0.8×	88 0.9×	42 0.4×	56 0.9×	62 1.6×	18	325
Tianying Zhong China	10	197 0.9×	24 0.2×	66 0.7×	147 2.5×	28 0.7×	20	359

Countries citing papers authored by Xiaopei Yan

Since Specialization

Citations

This map shows the geographic impact of Xiaopei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopei Yan more than expected).

Fields of papers citing papers by Xiaopei Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopei Yan. The network helps show where Xiaopei Yan may publish in the future.

Co-authorship network of co-authors of Xiaopei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopei Yan. A scholar is included among the top collaborators of Xiaopei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopei Yan. Xiaopei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Xu, Jingwei, et al.. (2023). Exosomal MFI2-AS1 sponge miR-107 promotes non-small cell lung cancer progression through NFAT5. Cancer Cell International. 23(1). 51–51. 17 indexed citations

Su, Li, Muyin Liu, Jinxiang Chen, et al.. (2023). L‐carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1‐Parkin‐dependent mitophagy through the CPT1a‐PHB2‐PARL pathways. Acta Physiologica. 238(3). e13975–e13975. 29 indexed citations

Yan, Xiaopei, et al.. (2021). Metagenomic next-generation sequencing of radial ultrasound bronchoscopy-guided “cocktail” specimens as an efficient method for the diagnosis of focal pulmonary infections: a randomised study. Annals of Palliative Medicine. 10(2). 2080–2088. 6 indexed citations

Yan, Xiaopei, et al.. (2020). Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study. Journal of Thoracic Disease. 12(10). 5347–5356. 8 indexed citations

Li, Xiang, Xiaopei Yan, Yanli Wang, et al.. (2017). NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells. Experimental Cell Research. 362(2). 489–497. 59 indexed citations

Wang, Yanli, Hui Kong, Xiaoning Zeng, et al.. (2016). Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells. Oncology Reports. 35(4). 2053–2064. 159 indexed citations

Li, Qinglin, Xiaopei Yan, Hui Kong, Weiping Xie, & Hong Wang. (2016). Iptakalim influences the proliferation and apoptosis of human pulmonary artery smooth muscle cells. Molecular Medicine Reports. 14(1). 715–720. 3 indexed citations

Yan, Xiaopei, et al.. (2016). Pulmonary Fungal Diseases in Immunocompetent Hosts: A Single-Center Retrospective Analysis of 35 Subjects. Mycopathologia. 181(7-8). 513–521. 11 indexed citations

Liu, Wenrui, Hui Kong, Xiaoning Zeng, et al.. (2015). Iptakalim inhibits PDGF-BB-induced human airway smooth muscle cells proliferation and migration. Experimental Cell Research. 336(2). 204–210. 26 indexed citations

10.

Yan, Xiaopei, et al.. (2014). [Analysis of pathogenic spectrum and risk factors in 165 non-transplant patients with invasive fungal disease].. PubMed. 37(7). 487–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact